Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Vanelle, J. M.
and
Douki, S.
2007.
Un ensayo comparativo doble ciego distribuido al azar de amisulprida frente a olanzapina durante 2 meses en el tratamiento de sujetos con esquizofrenia y depresion comorbida.
European psychiatry (Ed. Española),
Vol. 14,
Issue. 4,
p.
181.
Möller, Hans-Jürgen
2008.
Drug Treatment of Depressive Symptoms in Schizophrenia.
Clinical Schizophrenia & Related Psychoses,
Vol. 1,
Issue. 4,
p.
328.
Thomas, Pierre
Alptekin, Köksal
Gheorghe, Mihai
Mauri, Mauro
Olivares, José Manuel
and
Riedel, Michael
2009.
Management of Patients Presenting with Acute Psychotic Episodes of Schizophrenia.
CNS Drugs,
Vol. 23,
Issue. 3,
p.
193.
2009.
The Maudsley Prescribing Guidelines, Tenth Edition.
p.
9.
Komossa, Katja
Rummel-Kluge, Christine
Hunger, Heike
Schmid, Franziska
Schwarz, Sandra
Silveira da Mota Neto, Joaquim I
Kissling, Werner
and
Leucht, Stefan
2010.
Amisulpride versus other atypical antipsychotics for schizophrenia.
Cochrane Database of Systematic Reviews,
Vol. 2013,
Issue. 2,
Komossa, Katja
Rummel-Kluge, Christine
Hunger, Heike
Schmid, Franziska
Schwarz, Sandra
Duggan, Lorna
Kissling, Werner
and
Leucht, Stefan
2010.
Olanzapine versus other atypical antipsychotics for schizophrenia.
Cochrane Database of Systematic Reviews,
Nuss, Philippe
and
Tessier, Cedric
2010.
Antipsychotic medication, functional outcome and quality of life in schizophrenia: focus on amisulpride.
Current Medical Research and Opinion,
Vol. 26,
Issue. 4,
p.
787.
Citrome, Leslie
Holt, Richard I.G.
Walker, Daniel J.
and
Hoffmann, Vicki Poole
2011.
Weight Gain and Changes in Metabolic Variables following Olanzapine Treatment in Schizophrenia and Bipolar Disorder.
Clinical Drug Investigation,
Vol. 31,
Issue. 7,
p.
455.
Majadas, Susana
Olivares, Jose
Galan, Jaime
and
Diez, Teresa
2012.
Prevalence of depression and its relationship with other clinical characteristics in a sample of patients with stable schizophrenia.
Comprehensive Psychiatry,
Vol. 53,
Issue. 2,
p.
145.
Lee, Seung Jae
Lee, Jong Hun
Jung, Sung Won
Koo, Bon Hoon
Choi, Tae Young
and
Lee, Kwang Hun
2012.
A 6-Week, Randomized, Multicentre, Open-Label Study Comparing Efficacy and Tolerability of Amisulpride at a Starting Dose of 400 mg/day versus 800 mg/day in Patients with Acute Exacerbations of Schizophrenia.
Clinical Drug Investigation,
Vol. 32,
Issue. 11,
p.
735.
Purgato, Marianna
Adams, Clive
and
Barbui, Corrado
2012.
Schizophrenia trials conducted in African countries: a drop of evidence in the ocean of morbidity?.
International Journal of Mental Health Systems,
Vol. 6,
Issue. 1,
p.
9.
Moteshafi, Hoda
Zhornitsky, Simon
Brunelle, Sarah
and
Stip, Emmanuel
2012.
Comparing Tolerability of Olanzapine in Schizophrenia and Affective Disorders.
Drug Safety,
Vol. 35,
Issue. 10,
p.
819.
Moteshafi, Hoda
Zhornitsky, Simon
Brunelle, Sarah
and
Stip, Emmanuel
2012.
Comparing Tolerability of Olanzapine in Schizophrenia and Affective Disorders.
Drug Safety,
Vol. 35,
Issue. 10,
p.
819.
Safer, Daniel J.
and
Zito, Julie M.
2013.
Number Needed to Harm.
Journal of Nervous & Mental Disease,
Vol. 201,
Issue. 8,
p.
714.
Bak, Maarten
Fransen, Annemarie
Janssen, Jouke
van Os, Jim
Drukker, Marjan
and
Zhang, Xiang Yang
2014.
Almost All Antipsychotics Result in Weight Gain: A Meta-Analysis.
PLoS ONE,
Vol. 9,
Issue. 4,
p.
e94112.
George, Echim
Cucuiet, Sorina
Osz, Bianca
Grosan, Alexandra
Zsolt, Gal
and
Dogaru, Maria
2015.
Amisulpride - An Athypical Antipsychotic?.
Acta Medica Marisiensis,
Vol. 61,
Issue. 4,
p.
337.
Hasan, Alkomiet
Falkai, Peter
Wobrock, Thomas
Lieberman, Jeffrey
Glenthøj, Birte
Gattaz, Wagner F.
Thibaut, Florence
and
Möller, Hans-Jürgen
2015.
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia Part 3: Update 2015 Management of special circumstances: Depression, Suicidality, substance use disorders and pregnancy and lactation.
The World Journal of Biological Psychiatry,
Vol. 16,
Issue. 3,
p.
142.
Heres, Stephan
Cirjaliu, Diana Meliu
Dehelean, Liana
Matei, Valentin Petre
Podea, Delia Marina
Sima, Dorina
Stecher, Lynne
and
Leucht, Stefan
2016.
The SWITCH study: rationale and design of the trial.
European Archives of Psychiatry and Clinical Neuroscience,
Vol. 266,
Issue. 6,
p.
513.
Barbosa, Lucila
and
Bernardo, Miquel
2016.
Utilización de olanzapina en el tratamiento de la esquizofrenia y el trastorno bipolar.
Psiquiatría Biológica,
Vol. 23,
Issue. 1,
p.
4.
Tamilselvan, Thangavel
Siddique, Saiful Alom
Vishnupriya, Manikannan
Sindhu, Ganapathy
and
Balamurugan, Elumalai
2017.
Behavioral and neurochemical evaluation of ethanol on olanzapine treated methylphenidate induced manic like behaviors in swiss albino mice.
Beni-Suef University Journal of Basic and Applied Sciences,
Vol. 6,
Issue. 1,
p.
48.
Comments
No Comments have been published for this article.